News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Lindsay Admon, MD, MSc

Advertisement

Articles by Lindsay Admon, MD, MSc

Depressed pregnant woman

Behavioral health in pregnancy and postpartum

ByCaitlin E. Martin, MD, MPH,Lindsay Admon, MD, MSc,Mishka Terplan, MD, MPH
December 10th 2018

Women with behavioral conditions need ongoing care through pregnancy and postpartum, but our health care system makes this a challenge

Advertisement

Latest Updated Articles

  • Depressed pregnant woman
    Behavioral health in pregnancy and postpartum

    Published: December 10th 2018 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

FDA approves 5-year use for etonogestrel implant 68 mg contraceptive

2

Prenatal acid-suppressive medications not linked to neuropsychiatric disorders in offspring

3

Barbara Levy, MD: Patient-collected hrHPV testing is "huge" part of updated cervical cancer guideline

4

RE104 30 mg demonstrates efficacy and safety in new phase 2 data for postpartum depression

5

Barbara Levy, MD, reacts to HRSA's updated cervical cancer guidelines

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us